Florida Cancer Specialists & Research Institute physician leaders and pharmacy experts share insights at 2025 NCODA International Fall Summit. Read More
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome hematologist and medical oncologist Sireesha Datla, MD to the statewide practice. Read More
Drug shortages are a common issue in the health care industry. Florida Cancer Specialists & Research Institute (FCS) is highly skilled at proactively managing the drug supplies it needs to care for patients. However, a recent shortage of two critical chemotherapy drugs is impacting the lives of cancer patients and forcing oncologists to find alternative treatment options that are often less effective. Read More
Florida Cancer Specialists & Research Institute, LLC (FCS) is demanding reform in the pricing regulation of generic drugs, an issue that has deeply affected the oncology community for years but has worsened in recent months. Inadequacies in regulating average selling prices (ASP) for regimens crucial to patient care are directly affecting manufacturers’ ability to maintain operations and productivity for critical generic drugs. Read More
A collaboration between Florida Cancer Specialists & Research Institute, LLC (FCS) and Florida Blue, the state’s Blue Cross Blue Shield plan, is proving to enhance patient care and well-being while also keeping health care costs under control. Read More